Electron-transport chain
What it does, reaction by reaction
This enzyme appears only in the regulation table, with no catalysed step recorded.
What accelerates and inhibits it
Regulation is pathway-specific, so each context is listed separately
Ketolysis (Ketone Body Utilization)
ADP and oxygen availability
Hypoxia; high ATP/low ADP
No direct ketolysis-specific hormonal switch
Recent literature
Europe PMC · fetched just now · sorted by publication date
-
1
A programmable spatiotemporal bioelectrical conduit promotes peripheral nerve regeneration by suppressing ferroptosis through modulation of ER-mitochondria coupling in Schwann cells.
Wang Z, Jiang A, Wang F, Yang Z, Zhong Y, Yang Y, Tan J, Han W, Li X, He X, Zhang X, Wang J, Han X, Bai D. · 2026-09-16
open access unreviewed -
2
A transferrin receptor-targeted liposome for iron metabolism regulation-augmented photodynamic therapy in glioblastoma.
Wen R, He G, Wan Y, Guo X, Xiong S, Wu Y, Wei Y, Li D, Lin J, Huang P. · 2026-09-16
open access unreviewed -
3
Multienzymatic hybrid bio-heterojunction for synergistic microenvironment reprogramming and selenoprotein-activated mitochondrial bioenergetics in diabetic osseointegration.
Zhang M, Lu M, Chen Y, Ming M, Luo B, Wu Y. · 2026-09-16
open access unreviewed -
4
Artificial intelligence-guided nanozyme engineering for chronic wound healing: from rational design to precision therapeutics.
Yang D, Zheng Z, Wang H, Zhao H, Li Z, Liu Y, Xiong Y, Luo Z. · 2026-09-08
open access unreviewed -
5
Harnessing gasotransmitters for orthopaedic infection therapy: Mechanisms and advanced delivery platforms.
Zhang JY, Yang YQ, Zhang ZX, Jin JL, Luo ZY, Wang DY, Ruan CX, Dai TZ, Huang YL, Xu J, Shi JW, Li JY, Lei PF. · 2026-09-03
open access unreviewed -
6
In-situ chargeable, postcharging antibacterial supercapacitor patch with integrated pH sensing for infected chronic wound management.
Zou Y, Ji J, Yin S, Liu Z, Sun H. · 2026-08-03
unreviewed -
7
Nanoadjuvant-based membrane poration boosts antitumor immunity via modulating mitochondrial metabolism to downregulate PD-L1 and upregulate STING.
You W, Gao F, Wang HL, Shen AZ, Zhang Z, Nie X, Huang WQ, Wang LH, You YZ. · 2026-09-11
open access unreviewed -
8
ONC201/dordaviprone for H3 K27M-mutant tumors: Discovery, mechanisms, therapeutic potential, and future directions.
Pimentel JM, Zhou JY, Wu GS. · 2026-06-24
open access unreviewed -
9
Metabolic reprogramming in colorectal cancer: Mechanisms and therapeutic insights.
Xiao W, Tan D, Zeng W, Nie X, Wang M. · 2026-01-28
open access unreviewed -
10
A universal consuming endogenous H<sub>2</sub>S strategy using bismuth-metal-organic nanocapsule networks for overcoming osteosarcoma cisplatin resistance.
Lin Y, Yuan K, Liu Y, Du Y, Chang H, Hou L, Liang Y, Huang K, Yang S, Tang T. · 2026-08-18
open access unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.